Zentiva

Zentiva, a pharmaceutical preparation manufacturing company headquartered in CZ, has reported its carbon emissions for several years. In 2024, the company's total emissions, encompassing Scope 1, 2, and 3, were approximately 411.9 million kg CO2e. This figure comprises Scope 1 emissions of about 13.7 million kg CO2e, Scope 2 emissions (market-based) of approximately 14.1 million kg CO2e, and substantial Scope 3 emissions totalling around 384.1 million kg CO2e. The largest contributor to Scope 3 emissions in 2024 was purchased goods and services, accounting for roughly 308.1 million kg CO2e.

Prior to this, in 2023, Zentiva's total emissions were approximately 81.4 million kg CO2e, with Scope 1 at 15.0 million kg CO2e, Scope 2 at 13.6 million kg CO2e, and Scope 3 at 52.8 million kg CO2e. In 2022, total emissions stood at about 89.7 million kg CO2e (Scope 1: 18.1 million kg CO2e, Scope 2: 16.0 million kg CO2e, Scope 3: 55.7 million kg CO2e). In 2021, total emissions were approximately 78.4 million kg CO2e, consisting of Scope 1 emissions of 20.7 million kg CO2e, Scope 2 of 13.2 million kg CO2e, and Scope 3 of 44.6 million kg CO2e.

Zentiva's emissions data is cascaded from its parent organisation, Zentiva k.s. The company does not currently have publicly stated SBTi reduction targets or other specific reduction initiatives outlined.